Effects of Levistilide A on Hemorheology and Endothelial Cell Injury in Rats with Blood Stasis | Zendy

XiaoTong Liu | Zendy; Mijia Zhang | Zendy; Yujiao Li | Zendy; Weiqian He | Zendy; Guanghua Lu | Zendy; Qiong Wang | Zendy; QiaoZhi Wang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effects of Levistilide A on Hemorheology and Endothelial Cell Injury in Rats with Blood Stasis

Author(s) -

XiaoTong Liu,

Mijia Zhang,

Yujiao Li,

Weiqian He,

Guanghua Lu,

Qiong Wang,

QiaoZhi Wang

Publication year - 2021

Publication title -

evidence-based complementary and alternative medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.552

H-Index - 90

eISSN - 1741-4288

pISSN - 1741-427X

DOI - 10.1155/2021/6595383

Subject(s) - blood stasis , hemorheology , medicine , h&e stain , viability assay , fibrinogen , in vivo , endothelial stem cell , venous stasis , immunohistochemistry , blood viscosity , pathology , white blood cell , andrology , cell , chemistry , in vitro , biology , traditional chinese medicine , biochemistry , alternative medicine , microbiology and biotechnology

Background. Vascular endothelial cell injury is not only the initiating factor of cardiovascular and cerebrovascular diseases but also the essence of blood stasis. Levistilide A (LA), a natural component isolated from the traditional Chinese herb, Ligusticum chuanxiong Hort, has traditional effects on improving blood circulation and removing stasis. In this study, the effects and potential mechanisms of LA in the rat model of blood stasis and the mechanism in endothelial cell injury have been explored. Materials and Methods. In this experiment, the effects of LA on the model of acute blood stasis in rats were explored. The blood samples were collected for the measurement of coagulation and hemorheological indices, and the carotid arteries were also excised from rats for hematoxylin-eosin (HE) staining and immunohistochemistry (IHC). In addition, the improvement effects of LA on the H2O2-induced human umbilical vein endothelial cell (HUVEC) injury model were evaluated. And the cell viability detection was conducted by the CCK8 assay, and the pathway-related protein expressions were detected by western blotting. Results. In vivo, compared with the model group, the treatment of LA (10 mg/kg) could reduce the FIB (fibrinogen) content ( P < 0.01 ), increase the INR (international normalized ratio) and PT (prothrombin time) ( P < 0.01 ), and reduce the plasma viscosity ( P < 0.05 ) and whole blood viscosities of low, medium, and high shear rates in the blood of blood stasis model rats ( P < 0.01 ). In vitro, the cell viability in the LA-pretreated group was higher than that of the model group ( P < 0.05 ). The expression levels of PI3K, AKT, and eNOs in the LA-pretreated group were increased ( P < 0.01 ) as compared to the model group. Conclusion. These findings demonstrated that LA has the ability to improve blood hypercoagulation and blood viscosity, and enhance the viability of cells. It is more likely that it exerts a protective effect on the endothelial cell through the PI3K-AKT-eNOs pathway. These results indicate LA will be a potential candidate to cure blood stasis with endothelial cell injury.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research